samsung_bioepis

Ontruzant launches to become first Herceptin biosimilar available in the UK

March 8, 2018
Sales and Marketing Cancer, Herceptin, MSD, Ontruzant, Roche, Samsung Bioepis, pharma

Ontruzant, the biosimilar version of Herceptin (trastuzumab ) originally developed by Korean firm Samsung Bioepis, has launched for patients in …

evotec_credit_-_gregor_r

EvoTec to command vast Sanofi resources in infectious disease R&D partnership

March 8, 2018
Research and Development, Sales and Marketing Evotec, Sanofi, infectious disease, infective disease, pharma

Sanofi has announced it is to team up with biotech drug discovery specialist EvoTec to leverage a new open innovation …

shutterstock_273326141

Eisai and MSD team up to combine Lenvima and Keytruda in cancer

March 8, 2018
Sales and Marketing Cancer, Eisai, Kidney cancer, Lenvima, MSD, Merck, keytruda, pharma

Pharma heavyweights MSD (Merck) and Eisai have announced they are to join forces to develop and commercialise the latter’s tyrosine …

dengvaxia

Sanofi’s controversial dengue vaccine may still hit US market, despite Philippines disaster

March 7, 2018
Sales and Marketing FDA, Philippines, Sanofi, US, dengue, dengvaxia, pharma

Sanofi has revealed that the ongoing debacle in the Philippines concerning its dengue vaccine Dengvaxia has not deterred it from …

FDA greenlights alternative therapy for multidrug-resistant HIV patients

March 7, 2018
Research and Development, Sales and Marketing HIV, Theratechnologies, Trogarzo, pharma

Theratechnologies has revealed that Trogarzo has received approval from the FDA as a treatment of HIV-1 in patients with multidrug-resistant …

photo_credit_timothy_hale

Former Sanofi exec accused of sexting and indecent exposure demands €1.2m

March 7, 2018
Research and Development, Sales and Marketing Sanofi, pharma

A former Sanofi executive fired for sexting, indecent exposure and other alleged sexual harassment charges has been demanding up to …

diabetes-777001_960_720

Study reveals “concerning” low standards of type 2 diabetes drugs in India

March 7, 2018
Research and Development India, diabetes, pharma, regulatory, type 2 diabetes

In what they believe is the first study of its kind, a team of researchers at the University of Massachusetts …

japan-112722_640

Japan saves record $12.2bn in 2017 through greater generic use

March 7, 2018
Research and Development, Sales and Marketing Japan, generics, keytruda, opdivo, pharma

Through a concerted shift from branded drugs to generic equivalents as a means to lower prescription costs, Japan is estimated …

FDA authorises first direct-to-consumer test for BRCA mutations, with caveats

March 6, 2018
Research and Development, Sales and Marketing 23andME, BRCA, Cancer, FDA, breast cancer, ovarian cancer, pharma

The FDA has given its authorisation to the first ever direct-to-consumer (DTC) test to identify three BRCA gene mutations which …

gilead_hq_at_stockley_park_london

Switching to Gilead’s Biktarvy proves non-inferior in HIV patients

March 6, 2018
Manufacturing and Production, Research and Development Biktarvy, Gilead, HIV, pharma

Gilead has unveiled findings from two Phase 3 studies into the efficacy of switching to its three-drug combo Biktarvy (bictegravir/emtricitabine/tenofovir …

University of Adelaide is fighting antibiotic-resistant superbugs by starving them of iron

March 6, 2018
Manufacturing and Production, Research and Development Adelaide, Australia, Superbugs, antibiotic resistance, pharma

A team of researchers from Australia’s University of Adelaide have developed a new method to fighting antibiotic-resistant bacteria by starving …

martin_shkreli_2016

Martin Shkreli ordered to forfeit $7.36m ahead of fraud sentencing

March 6, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Martin Shkreli, pharma

Reviled pharma bro Martin Shkreli is experiencing another heavy dose of karma after a US judge ordered him to forfeit …

dermira_logo

Dermira terminates acne drug after Phase 3 failure, wiping $667m from market value

March 5, 2018
Manufacturing and Production, Research and Development Dermira, acne, pharma, trial failure

Skin specialist biopharma firm Dermira has seen its stock crash and burn following the announcement that it plans to terminate …

gilead-sciences

Gilead investigational data gives hope for HIV eradication in humans

March 5, 2018
Research and Development, Sales and Marketing Gilead, HIV, pharma

Gilead has lifted the curtain on new preclinical data on the efficacy of a combo therapy of GS-9620, its investigational …

FDA finds major manufacturing issues at key Aurobindo facility

March 5, 2018
Manufacturing and Production, Sales and Marketing Aurobindo, FDA, pharma

Indian pharmaceutical firm Aurobindo has been rocked by an USFDA review which identified nine major issues with its Unit 4 …

celgene_1_02

Celgene strikes $101m partnership in oncology, neurodegenerative and inflammatory

March 5, 2018
Research and Development, Sales and Marketing Cancer, Celgene, Vividion, inflammatory, neurodegenerative, oncology, pharma

Celgene has inked a new multi-year partnership with biotech firm Vividion Therapeutics to leverage the latter’s proteomics and chemistry platforms …

mri_credit_-_ptrump16

NHS trials “world-leading” initiative to cut prostate cancer diagnoses to just days

March 5, 2018
Research and Development, Sales and Marketing Cancer, MRI, NHS, pharma, prostate cancer

The NHS has revealed plans to cut the average diagnosis times for prostate cancer from six weeks to less than …

Abbvie and Biogen pull MS drug Zinbryta following urgent EMA safety review

March 5, 2018
Sales and Marketing AQbbvie, Biogen, EMA, Europe, mulyiple sclerosis, pharma, zinbryta

Biogen and Abbvie have announced their intention to voluntarily withdraw their multiple sclerosis therapy Zinbryta (daclizumab) from all global markets …

The Gateway to Local Adoption Series

Latest content